U.S.–India Medicine Partnership

32 Pages

This report highlights India’s critical role in supplying affordable medicines to the U.S. healthcare system. Indian pharmaceutical companies provide a large share of U.S. generic prescriptions, generating substantial cost savings and improving access to chronic disease treatments. The report also examines supply chain risks related to active pharmaceutical ingredients and outlines opportunities for deeper U.S.–India collaboration to enhance resilience, affordability, and sustainability of medicine supply.

Join for free to read

Case Study Idaho College of Osteopathic Medicine & Druva Security…

Case Study ECU School of Dental Medicine

White Paper ADOPTING PRECISION MEDICINE WITH SMART PLATFORM

Report A new era of precision medicine

More from IQVIA

White Paper Digital Twins in Healthcare: Unlocking the Future of…

Report Understanding Medicine Spending in Australia

Report Medicine Spending and Affordability in the United States…

Report Global Medicine Spending and Usage Trends

Report

U.S.–India Medicine Partnership

U.S.–India Medicine Partnership

You Might Also Like

More from IQVIA